DrugDashboards

Sinuva

mometasone furoate · MOMETASONE FUROATE 1350 ug/1 · Implant · Intrasinal · Intersect ENT, Inc.

NDC 10599-0003-01 · 1 POUCH in 1 CARTON / 1 IMPLANT in 1 POUCH · NDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Medicare Part B pays (ASP+6%)$11.35per billing unit (10 MCG)HCPCS J7402 · Jul 1, 2026
  • Part D plans paid (avg)$117.78per dosage unitgross, before rebates — matched by drug name · 2024
  • Federal ceiling (Big4)$1,103.61per unitIntersect ENT, Inc. DBA Intersect · Jan 1, 2026

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$1,474.35
Reported to Texas DSHS · 2026 annual filing · Intersect ENT, Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 10 MCG
$11.345
HCPCS J7402 · Jul 1, 2026 quarter · typically ASP + 6%

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for mometasone furoate (other) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
NDA209310
TE code
Approval date
Dec 8, 2017
Patents / exclusivity
7 patents, 0 exclusivities
TypeNumber / codeExpires
patent10232152Nov 24, 2034
patent10406332Mar 13, 2034
patent8763222Feb 8, 2032
patent10357640Oct 3, 2031
patent8025635Jun 12, 2027
patent7544192Nov 29, 2026
patent9585681Apr 4, 2026

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedJan 4, 2023
    Intersect ENT, Inc.Failed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.

Manufacturers of mometasone furoate (Implant)

LabelerStrengthFirst seenLast seen
Intersect ENT, Inc.MOMETASONE FUROATE 1350 ug/1Jul 15, 2026Sep 2, 2026
Synergy Health, LLCMOMETASONE FUROATE 1350 ug/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Sinuva — NDC 10599-0003-01," retrieved September 3, 2026, https://drugdashboards.com/drug/10599000301.

Free to cite with attribution — see how the data is put together.